Customer experience (CX) programs that have been running for several years are often in a Catch-22: the program has lost buy-in because it is not perceived to produce actionable insights; however, ...

Progress in the clinical development of CX-2051, targeted at advanced colorectal cancer, with initial Phase 1a clinical data expected in the first half of 2025. CytomX maintains a strong financial ...

About VistaXM VistaXM is the creator of CX-as-a-Service (CXaaS), a fully managed customer experience delivery model built for mid-market B2B companies. VistaXM operates complete CX programs end-to-end ...

We get lost in CX metrics acronym bingo, and use these as the defining standard of our CX program. There's a better way. NPS. CLI. CSAT. CES. CLV. And on and on and on. Most of us have tried it all — ...

CytomX Therapeutics has updated its pipeline priorities for 2025, highlighting its lead program, CX-2051, a first-in-class PROBODY ADC targeting EpCAM for advanced metastatic colorectal cancer, with ...

Customer experience (CX) programs that exceed management expectations are 2.3 times more likely to have CX efforts in marketing not primarily focused on the path to purchase but on the journey after ...

THE CHALLENGES OF 2022 will create an inflection point for customer experience (CX) programs in 2023—and many will not survive. Last year was a rough one for CX programs as companies lost their focus ...

Survey of 160+ CX decision makers at global enterprises finds customer frustration with automation and chatbots to be top challenge in delivering effective customer service Value-based routing–the ...

The challenges of 2022 — when companies lost their customer focus amid rising customer expectations and a worsening economy — will create an inflection point for customer experience (CX) programs in ...